Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-01-02Clinical Trial Update: The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo Device [Phase 3]
A Phase 3 clinical trial evaluating a novel in vivo device for detecting circulating tumor cells in breast cancer.
-
CLINICAL_TRIALS other · 2017-01-02Clinical Trial Update: Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients [Phase 2]
Phase 2 clinical trial investigating fulvestrant with exemestane endocrine therapy for postmenopausal advanced breast cancer; current status…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment [Phase 4]
This Phase 4 trial evaluated trastuzumab (Herceptin) in combination with a taxane in patients with HER2-positive breast cancer who relapsed …
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer [Phase 1]
This document reports a completed Phase 1 clinical trial evaluating celecoxib in postmenopausal women undergoing surgery for invasive breast…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer [Phase 1]
This is a Phase I prevention trial evaluating atorvastatin in women at increased risk for breast cancer. The study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-12-28Clinical Trial Update: PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer
A completed clinical trial evaluating PET scans to assess treatment response in breast cancer patients receiving hormone therapy or trastuzu…
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast Cancer [Phase 3]
A Phase 3 trial evaluated whether thoracic paravertebral block reduces acute postoperative pain in breast cancer surgery. The study has comp…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Specimen X-Rays of Removed Axillary Lymph Nodes to Guide Pathological Sampling
A completed trial evaluated whether specimen X-rays of removed axillary lymph nodes can guide targeted pathological sampling in breast cance…
-
CLINICAL_TRIALS research · 2016-12-23Clinical Trial Update: Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast Cancer [NA]
Clinical trial update on hippocampal-sparing whole-brain radiotherapy for brain metastases arising from breast cancer. The current status of…
-
CLINICAL_TRIALS trial_result · 2016-12-21Clinical Trial Update: Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients [NA]
The study evaluating doxorubicin-associated cardiac remodeling with cardiac MRI in breast cancer patients has completed.
-
CLINICAL_TRIALS research · 2016-12-20Clinical Trial Update: Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
This clinical trial update reports on the feasibility of assessing breast cancer risk in women from the general population.
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life [NA]
A completed clinical trial comparing progressive resistance training versus relaxation in breast cancer patients undergoing chemotherapy, in…
-
CLINICAL_TRIALS research · 2016-12-19Clinical Trial Update: Improved Breast MRI With SWIFT [NA]
A clinical trial update discusses the SWIFT-enhanced breast MRI technique for assessing breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Breast Cancer Risk Biomarkers in Postmenopausal Women [Phase 2]
Phase 2 trial investigating breast cancer risk biomarkers in postmenopausal women; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females [Phase 1]
This Phase 1 dose-finding trial evaluated subcutaneous trastuzumab (Herceptin) in healthy male volunteers and HER2-positive females with bre…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer [Phase 1]
Phase 1 trial evaluating a peptide-based vaccine designed to elicit T cell responses in patients with breast cancer; the study has completed…
-
CLINICAL_TRIALS research · 2016-12-16Clinical Trial Update: Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound
This entry provides an update on an ongoing clinical trial evaluating predicting axillary metastasis risk in female breast cancer patients u…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial update on ABI-007 (Abraxane) in taxol-resistant metastatic breast cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer [Phase 1]
This Phase 1 trial evaluated GDC-0941 (pictilisib) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with let…
-
FDA approval · 2016-12-14FDA Approved: FLUOROURACIL — Supplemental Application (Eugia US LLC)
The FDA has approved a supplemental application for Fluorouracil from Eugia US LLC, formalizing an update to the product under the ANDA path…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial investigating pazopanib for recurrent or metastatic breast cancer has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC). [Phase 1]
This Phase 1 study evaluated the combination of lurbinectedin with capecitabine in patients with metastatic breast cancer, pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Upper Limb Muscular Strengthening in the Rehabilitation of Patients Submitted to the Breast Cancer Surgical Treatment [NA]
A completed clinical trial assessing upper limb muscular strengthening for rehabilitation after breast cancer surgery.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Citalopram in Treating Postmenopausal Women With Hot Flashes [Phase 3]
Phase 3 clinical trial evaluating citalopram for treating hot flashes in postmenopausal women has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating irinotecan in combination with docetaxel for refractory metastatic breast cancer; the study status is comp…